These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 2667784)

  • 1. Hypercalcaemia of malignancy.
    Kelly PJ; Eisman JA
    Cancer Metastasis Rev; 1989 Jun; 8(1):23-52. PubMed ID: 2667784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
    Ralston SH; Fogelman I; Gardiner MD; Boyle IT
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.
    Ralston SH; Fogelman I; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
    Clin Sci (Lond); 1984 Feb; 66(2):187-91. PubMed ID: 6692653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypercalcaemia of malignancy with clodronate.
    Bonjour JP; Rizzoli R
    Bone; 1991; 12 Suppl 1():S19-23. PubMed ID: 1835397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of hypercalcaemia of malignancy.
    Mundy GR
    Clin Endocrinol (Oxf); 1985 Dec; 23(6):705-14. PubMed ID: 3006948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and management of cancer associated hypercalcaemia.
    Ralston SH
    Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
    Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
    Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
    Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
    Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of humoral hypercalcaemia of malignancy.
    Ralston SH
    Lancet; 1987 Dec; 2(8573):1443-6. PubMed ID: 2892002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.
    Ralston SH; Boyce BF; Cowan RA; Gardner MD; Dryburgh FJ; Boyle IT
    Q J Med; 1986 Mar; 58(227):325-35. PubMed ID: 3016790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcaemia and hypocalcaemia: finding the balance.
    Body JJ; Niepel D; Tonini G
    Support Care Cancer; 2017 May; 25(5):1639-1649. PubMed ID: 28078478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
    Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of early diagnosis of cancer-related hypercalcaemia].
    Radványi I; Csikós A; Balogh S
    Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
    Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
    Mantzoros CS; Suva LJ; Moses AC; Spark R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong.
    Shek CC; Natkunam A; Tsang V; Cockram CS; Swaminathan R
    Q J Med; 1990 Dec; 77(284):1277-85. PubMed ID: 2290921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twist on a classic: vitamin D and hypercalcaemia of malignancy.
    Osorio JC; Jones MG; Schatz-Siemers N; Tang SJ
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy.
    Firkin F; Seymour JF; Watson AM; Grill V; Martin TJ
    Br J Haematol; 1996 Sep; 94(3):486-92. PubMed ID: 8790147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.